Clinical Trial Update: Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating apatinib in combination with ifosfamide and etoposide for relapsed or refractory osteosarcoma; the study status is susp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Apatinib (apatinib)
• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Effect of Drug, Toxicity, Drug | Phase 2 | Status: SUSPENDED